NOS3, nitric oxide synthase 3, 4846

N. diseases: 706; N. variants: 39
Disease: Mammary Neoplasms ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms 		0.360 Biomarker group CTD_human Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial. 19671875 2009
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms 		0.360 GeneticVariation group LHGDN Genetic polymorphisms and haplotypes of eNOS in breast cancer. 17592771 2008
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms 		0.360 GeneticVariation group LHGDN Relationships between polymorphisms in NOS3 and MPO genes, cigarette smoking and risk of post-menopausal breast cancer. 17259657 2007
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms 		0.360 GeneticVariation group LHGDN Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer. 17726138 2007
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms 		0.360 GeneticVariation group LHGDN Genetic polymorphisms of NOS3 are associated with the risk of invasive breast cancer with lymph node involvement. 17262178 2007
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms 		0.360 GeneticVariation group LHGDN Genetic polymorphisms of eNOS, hormone receptor status, and survival of breast cancer. 16821086 2006
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms 		0.360 AlteredExpression group LHGDN Reduced expression of endothelial and inducible nitric oxide synthase in a multidrug resistant variant of the MCF-7 human breast cancer cell line. 15492785 2004
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms 		0.360 Biomarker group CTD_human Antioxidative response for nitric oxide production in breast carcinoma. 15375496 2004